Saturday, April 17, 2021

Centre waives import duty, GST worth Rs 6 cr on infant’s imported medicines

cash, currency, notes, funds, investment, shares, growth, profit, loss, tax, money, income, earnings

The Union government has waived

and of Rs 6 crore on medicines for a five- month-old girl suffering from a rare medical condition, BJP leader Devendra Fadnavis said on Tuesday.

Teera Kamat, admitted in a suburban hospital, suffers from Spinal Muscular Atrophy in which a complete breakdown of nerve cells results in zero control over muscle movement.

Her parents, Priyanka and Mihir Kamat, had written on social media about their child’s fight with a debilitating ailment, leading to fund raising as well as appeals to the Union government to waive and on medicines.

Among the medicines is Zolgensma which targets the root cause of SMA and which has to be imported.

In their social media appeals, Teera’s parents had said that 23 per cent and 12 per cent added Rs 6 crore to the cost of Rs 16 crore that the treatment entails.

Fadnavis, on February 1, had written to the Centre requesting a waiver of import duty and GST.

“I would like to thank you from bottom of my heart for extremely humanitarian and sensitive approach and quick action for exempting customs duty for importing life saving drug Zolgensma for five month old Teera Kamat from Mumbai,” Fadnavis said in a letter to the Prime Minister’s Office on Tuesday.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Source link

Leave a Response